Health
Study: Hydroxychloroquine plus azithromycin linked to significant cardiovascular risks – News-Medical.Net
The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM.
Reviewed by Emily Henderson, B.Sc.Aug 25 2020
The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM. This network study, led by the Observational Health Data Sciences and Informatics community, was recently published in Lancet Rheumatology.
OHDSI has established an international network of researchers and observational health databases with a…
-
Noosa News23 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News24 hours agoMotorcyclist dies in crash with truck
-
Noosa News22 hours agoAustralia Post reintroduces weekend deliveries for Christmas parcel rush
-
General18 hours agoFederal government funding extends cohealth GP services until July 2026
